PAPI, Alberto
 Distribuzione geografica
Continente #
NA - Nord America 41.178
AS - Asia 23.922
EU - Europa 12.629
SA - Sud America 4.271
AF - Africa 626
OC - Oceania 183
Continente sconosciuto - Info sul continente non disponibili 24
Totale 82.833
Nazione #
US - Stati Uniti d'America 40.350
SG - Singapore 9.109
CN - Cina 5.202
BR - Brasile 3.272
VN - Vietnam 2.701
IT - Italia 2.502
HK - Hong Kong 2.361
DE - Germania 1.894
UA - Ucraina 1.885
FI - Finlandia 1.325
GB - Regno Unito 1.223
TR - Turchia 1.185
FR - Francia 850
JP - Giappone 730
NL - Olanda 724
RU - Federazione Russa 643
SE - Svezia 539
IN - India 535
ID - Indonesia 521
MX - Messico 393
AR - Argentina 370
BD - Bangladesh 317
CA - Canada 307
PL - Polonia 284
IQ - Iraq 195
ZA - Sudafrica 184
AU - Australia 161
EC - Ecuador 155
PK - Pakistan 153
ES - Italia 134
CO - Colombia 129
AT - Austria 122
PH - Filippine 117
MA - Marocco 94
VE - Venezuela 88
MY - Malesia 86
SA - Arabia Saudita 85
PY - Paraguay 83
BE - Belgio 77
UZ - Uzbekistan 76
KR - Corea 74
LT - Lituania 69
TN - Tunisia 66
CL - Cile 65
EG - Egitto 65
TW - Taiwan 64
AE - Emirati Arabi Uniti 62
KE - Kenya 59
PE - Perù 51
CZ - Repubblica Ceca 50
TH - Thailandia 42
DZ - Algeria 41
IE - Irlanda 38
CH - Svizzera 36
UY - Uruguay 31
JO - Giordania 30
NP - Nepal 30
KZ - Kazakistan 28
LB - Libano 26
PT - Portogallo 26
RO - Romania 26
AL - Albania 25
AZ - Azerbaigian 24
BO - Bolivia 22
IL - Israele 22
GR - Grecia 21
IR - Iran 21
JM - Giamaica 21
NZ - Nuova Zelanda 20
ET - Etiopia 19
PS - Palestinian Territory 18
DO - Repubblica Dominicana 16
HR - Croazia 16
RS - Serbia 15
BG - Bulgaria 14
CR - Costa Rica 14
EU - Europa 13
GE - Georgia 13
HN - Honduras 12
NG - Nigeria 12
PA - Panama 12
BH - Bahrain 11
MK - Macedonia 11
OM - Oman 11
GT - Guatemala 10
HU - Ungheria 10
SN - Senegal 10
SY - Repubblica araba siriana 10
NI - Nicaragua 9
SI - Slovenia 9
XK - ???statistics.table.value.countryCode.XK??? 9
DK - Danimarca 8
KH - Cambogia 8
MD - Moldavia 8
VI - Stati Uniti Isole Vergini 8
AO - Angola 7
BY - Bielorussia 7
CY - Cipro 7
LK - Sri Lanka 7
MN - Mongolia 7
Totale 82.657
Città #
Singapore 5.595
Ashburn 4.827
Fairfield 4.048
Woodbridge 3.629
Houston 2.642
San Jose 2.340
Hong Kong 2.316
Jacksonville 2.041
Santa Clara 1.634
Chandler 1.631
Seattle 1.529
Wilmington 1.435
Ann Arbor 1.327
Cambridge 1.319
Beijing 1.317
Dallas 1.269
Ho Chi Minh City 887
Helsinki 732
Izmir 702
Tokyo 688
Nanjing 639
Hanoi 630
Los Angeles 592
Council Bluffs 568
Princeton 564
Lauterbourg 549
Munich 520
New York 463
Jakarta 374
San Diego 371
Ferrara 346
Milan 339
Boardman 313
São Paulo 277
Mexico City 248
Warsaw 247
Chicago 246
Washington 240
Shanghai 217
Nanchang 195
Tianjin 178
Shenyang 173
London 158
Hefei 154
Frankfurt am Main 142
Moscow 142
Buffalo 137
Addison 131
Orem 131
Da Nang 130
Hebei 124
Rome 124
Lappeenranta 116
Changsha 115
Dearborn 109
Nuremberg 108
Haiphong 103
Rio de Janeiro 103
Jiaxing 101
Turku 93
Dong Ket 90
Mountain View 86
Denver 85
Brooklyn 84
Guangzhou 84
Toronto 83
Montreal 82
Chennai 80
The Dalles 80
Falls Church 79
Baghdad 78
Falkenstein 76
Bologna 75
Atlanta 74
Redwood City 74
Zhengzhou 70
Boston 69
Norwalk 66
Tashkent 66
Belo Horizonte 65
Johannesburg 65
Stockholm 61
Vienna 61
Amsterdam 60
Curitiba 60
Manchester 57
Mumbai 55
Phoenix 55
Quito 55
Jinan 54
Dhaka 53
Kunming 52
San Francisco 52
Sydney 51
Biên Hòa 50
Brussels 50
Bremen 49
Ningbo 48
Lahore 47
Naples 47
Totale 55.046
Nome #
Real-World Experience with Dupilumab in Severe Asthma: One-Year Data from an Italian Named Patient Program 675
Asthma 498
Asthma death. Part 1: Clinical phenotypes, epidemiology and risk factors 447
Value of fiberoptic bronchoscopy in addition to 18F-FDG-PET/CT in the differentiation of solitary pulmonary nodules: a prospective study 429
Role of Stem Cells in the Pathogenesis of COPD and Pulmonary Emphysema 338
Infections and airway inflammation in chronic obstructive pulmonary disease severe exacerbations 337
Efficacy and safety of tezepelumab versus placebo in adults with moderate to very severe chronic obstructive pulmonary disease (COURSE): a randomised, placebo-controlled, phase 2a trial 317
Severe pneumonia after intravesical BCG instillation in a patient with invasive bladder cancer: case report and literature review 307
Polmonite da ipersensibilità da antigeni aviari in un italiano adulto 306
Targeting Th2 cells in asthmatic airways 298
Long-term effects of inhaled corticosteroids on sputum bacterial and viral loads in COPD 275
Chronic Obstructive Pulmonary Disease and Ischemic Heart Disease Comorbidity: Overview of Mechanisms and Clinical Management 260
Single inhaler extrafine triple therapy versus long-acting muscarinic antagonist therapy for chronic obstructive pulmonary disease (TRINITY): a double-blind, parallel group, randomised controlled trial 258
An official American Thoracic Society/European Respiratory Society statement: research questions in COPD 255
Alteration of adenosine receptors in patients with chronic obstructive pulmonary disease 252
Regular versus as-needed budesonide and formoterol combination treatment for moderate asthma: a non-inferiority, randomised, double-blind clinical trial 252
Th2 cytokines impair innate immune responses to rhinovirus in respiratory epithelial cells 252
Echocardiography, Spirometry, and Systemic Acute-Phase Inflammatory Proteins in Smokers with COPD or CHF: An Observational Study 250
Extrafine inhaled triple therapy versus dual bronchodilator therapy in chronic obstructive pulmonary disease (TRIBUTE): a double-blind, parallel group, randomised controlled trial 249
Intravenous N-acetylcysteine in respiratory disease with abnormal mucus secretion 246
Endothelial dysfunction and increased platelet reactivity in patients with acute coronary syndrome and undiagnosed COPD: insights into the SCAP trial 246
Primary pulmonary epithelioid hemangioendothelioma: A rare cause of PET-negative pulmonary nodules 243
Emphysema contribution to the progression of chronic obstructive pulmonary disease. 236
Inhaled corticosteroid/long-acting bronchodilator treatment mitigates STEMI clinical presentation in COPD patients 235
COPD increases the risk of squamous histological subtype in smokers who develop non-small cell lung carcinoma 234
Oxygen radical scavengers inhibit clastogenic activity induced by sonication of human serum 233
A human rhinovirus model of chronic obstructive pulmonary disease exacerbations 230
Deficient antiviral immune responses in childhood: Distinct roles of atopy and asthma 229
Bronchopulmonary inflammation and airway smooth muscle hyperresponsiveness induced by nitrogen dioxide in guinea pigs 224
Blood Eosinophils and Chronic Obstructive Pulmonary Disease: A GOLD Science Committee 2022 Review 221
ALTERATION OF ADENOSINE RECEPTORS IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE 218
Airway inflammation and illness severity in response to experimental rhinovirus infection in asthma 217
Blood Interferon-α Levels and Severity, Outcomes, and Inflammatory Profiles in Hospitalized COVID-19 Patients 216
A serum proteome signature to predict mortality in severe COVID-19 patients 214
Extrafine Versus Fine Inhaled Corticosteroids in Relation to Asthma Control: A Systematic Review and Meta-Analysis of Observational Real-Life Studies 214
Dupilumab reduces exacerbations and improves lung function in patients with chronic obstructive pulmonary disease and emphysema: Phase 3 randomized trial (BOREAS) 213
Effect of subchronic in vivo exposure to nitrogen dioxide on lung tissue inflammation, airway microvascular leakage, and in vitro bronchial muscle responsiveness in rats 212
Alteration of adenosine receptore in patients with chronic obstructive pulmonary disease 212
Cardiac troponin elevation predicts all-cause mortality in patients with acute exacerbation of chronic obstructive pulmonary disease: Systematic review and meta-analysis 211
Reducing agents decrease the oxidative burst and improve clinical outcomes in COPD patients: A randomised controlled trial on the effects of sulphurous thermal water inhalation 211
Beclometasone-formoterol as maintenance and reliever treatment in patients with asthma: a double-blind, randomised controlled trial 210
Description of a randomised controlled trial of inhaled corticosteroid/fast-onset LABA reliever therapy in mild asthma 210
Association of increased CCL5 and CXCL7 chemokine expression with neutrophil activation in severe stable COPD 209
M3 muscarinic receptors in peripheral lung parenchima of patients with chronic obstructive pulmonary disease. 208
Diffuse pulmonary meningothelial like nodules simulating metastatic thymoma 208
Management of COPD exacerbations: a European Respiratory Society/American Thoracic Society guideline 208
Malattie polmonari primitive da cause dismetaboliche. 207
Activation of NF-kappaB transcription factor in asthma death 206
Airway inflammatory profile is correlated with symptoms in stable COPD: A longitudinal proof-of-concept cohort study 205
Single inhaler triple therapy versus inhaled corticosteroid plus long-acting β2-agonist therapy for chronic obstructive pulmonary disease (TRILOGY): a double-blind, parallel group, randomised controlled trial 204
A role for phosphoinositol 3-kinase delta in the impairment of glucocorticoid responsiveness in patients with chronic obstructive pulmonary disease 202
Blood eosinophils and treatment response with triple and dual combination therapy in chronic obstructive pulmonary disease: analysis of the IMPACT trial 201
Enfisema polmonare: prospettive di terapia 200
T helper type 17-related cytokine expression is increased in the bronchial mucosa of stable chronic obstructive pulmonary disease patients 200
COPD: early diagnosis and treatment to slow disease progression 200
Immune Response to Mycobacterium tuberculosis Infection in the Parietal Pleura of Patients with Tuberculous Pleurisy 200
Fixed airflow obstruction due to asthma or chronic obstructive pulmonary disease: 5-year follow-up 200
Underuse of spirometry by general practitioners for the diagnosis of COPD in Italy 199
A new combination therapy for asthma: bridging the gap between effectiveness in trials and clinical practice? 198
Asthma management 198
A defective type 1 response to rhinovirus in atopic asthma 197
Predischarge screening for chronic obstructive pulmonary disease in patients with acute coronary syndrome and smoking history 197
Cellule staminali e patologia polmonare dell’adulto 196
Long-Term Fluticasone Propionate/Formoterol Fumarate Combination Therapy Is Associated with a Low Incidence of Severe Asthma Exacerbations 196
Inhaler Errors in the CRITIKAL Study: Type, Frequency, and Association with Asthma Outcomes 196
A Novel Insight into Adaptive Immunity in Chronic Obstructive Pulmonary Disease B Cell Activating Factor Belonging to the Tumor Necrosis Factor Family 196
Interleukin-13 and-4 expression in the central airways of smokers with chronic bronchitis 195
Efficacy and safety of benralizumab for patients with severe asthma uncontrolled with high-dosage inhaled corticosteroids and long-acting β2-agonists (SIROCCO): a randomised, multicentre, placebo-controlled phase 3 trial 195
Role of xanthine oxidase activation and reduced glutathione depletion in rhinovirus induction of inflammation in respiratory epithelial cells 192
Models of infection and exacerbations in COPD. 190
Apporto esogeno di riducenti e attività del rinovirus HRV16 190
A valid option for asthma control: Clinical evidence on efficacy and safety of fluticasone propionate/formoterol combination in a single inhaler 190
Circulating endothelial stem cells are not decreased in pulmonary emphysema or COPD 190
Rhinovirus vaccination: the case against 189
Phospho-p38 MAPK expression in COPD patients and asthmatics and in challenged bronchial epithelium 189
A randomized, double-blinded, double-dummy efficacy and safety study of budesonide-formoterol Spiromax® compared to budesonide-formoterol Turbuhaler® in adults and adolescents with persistent asthma 188
Increased expression of aquaporin 5 in bronchial glands of smokers with or without COPD 188
The C-C chemokine receptors CCR4 and CCR8 identify airway T cells of allergen-challenged atopic asthmatics 187
Ectopic thymoma simulating a pericardial cyst: case report 187
Natural Killer Cells in SARS-CoV-2-Vaccinated Subjects with Increased Effector Cytotoxic CD56dim Cells and Memory-Like CD57+NKG2C+CD56dim Cells 185
Severe Pneumonia following intravescical BCG therapy in a patient with bladder cancer. 185
An Official American Thoracic Society/European Respiratory Society Statement: Research questions in chronic obstructive pulmonary disease 185
COPD exacerbations: definitions and classifications 184
Dual Bronchodilation Response by Exacerbation History and Eosinophilia in the FLAME Study 184
N-acetylcysteine Treatment in Chronic Obstructive Pulmonary Disease (COPD) and Chronic Bronchitis/Pre-COPD: Distinct Meta-analyses 183
Association between markers of emphysema and more severe chronic obstructive pulmonary disease 183
Slower rise of exhaled breath temperature in chronic obstructive pulmonary disease 183
An unusual case of congenital short trachea with very long bronchi mimicking bronchial asthma 183
Efficacy of fluticasone propionate/formoterol fumarate in the treatment of asthma: A pooled analysis 183
Mechanisms of rhinovirus-induced asthma 183
Management of bronchial asthma 182
Exploring the relevance and extent of small airways dysfunction in asthma (ATLANTIS): baseline data from a prospective cohort study 181
Role of stem cells in the pathogenesis of chronic obstructive pulmonary disease and of pulmonary emphysema 180
Differences in airway inflammation in patients with fixed airflow obstruction due to asthma or chronic obstructive pulmonary disease 179
B Cell Activating Factor (BAFF) Is Expressed by Lymphoid Follicles of COPD Patients 179
Helicobacter pylori and chronic bronchitis 179
Right Ventricle Function in Patients with Acute Coronary Syndrome and Concomitant Undiagnosed Chronic Obstructive Pulmonary Disease 179
Xanthine oxidase activation by HRV16 infection in respiratory epithelial cells 178
Goblet cell hyperplasia and epithelial inflammation in peripheral airways of smokers with both symptoms of chronic bronchitis and chronic airflow limitation 178
Circulating Endothelial Stem Cells in Age-Matched Smokers with or without Mild-to-Moderate Pulmonary Emphysema 177
Totale 22.504
Categoria #
all - tutte 379.024
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 17.387
Totale 396.411


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.540 0 0 0 0 0 0 0 0 0 0 881 659
2021/20225.146 219 452 320 258 197 236 283 293 204 380 461 1.843
2022/20234.213 575 103 145 491 619 645 179 385 531 65 314 161
2023/20242.742 248 267 113 83 137 279 78 136 88 259 348 706
2024/202511.287 303 293 998 331 1.307 813 351 716 1.934 1.653 1.447 1.141
2025/202634.058 2.708 1.677 3.921 4.392 4.676 2.199 4.067 2.238 3.792 4.235 153 0
Totale 84.136